BlackRock Innovation and Growth Term Trust (BIGZ)
After hours:
| Previous Close | 7.37 |
| Open | 7.44 |
| Bid | 7.21 x 4000 |
| Ask | 7.50 x 800 |
| Day's Range | 7.31 - 7.46 |
| 52 Week Range | 6.21 - 8.35 |
| Volume | |
| Avg. Volume | 637,617 |
| Market Cap | 1.674B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 7.61 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.55 (8.06%) |
| Ex-Dividend Date | Oct 13, 2023 |
| 1y Target Est | N/A |
- Business Wire
Saba Capital Shares Key Facts That Reinforce the Urgent Need for Change at 10 BlackRock Closed-End Funds
NEW YORK, May 30, 2024--Saba Capital Management, L.P. (together with certain of its affiliates, "Saba" or "we") today sent the below letter to shareholders of 10 BlackRock closed-end funds (collectively, the "Funds" or the "CEFs")1 where Saba has nominated independent directors for election to the Funds’ Boards of Trustees (the "Boards") at the upcoming 2024 Annual Meetings of Shareholders (the "Annual Meetings").
- Business Wire
Saba Capital Releases Presentation Detailing Plan to Deliver Enhanced Shareholder Value at 10 BlackRock Closed-End Funds
NEW YORK, May 20, 2024--Saba Capital Management, L.P. (together with its affiliates, "Saba" or "we") today issued a presentation detailing its plan to deliver shareholder value at 10 BlackRock Advisors, LLC ("BlackRock") closed-end funds (collectively, the "Funds").1 The presentation can be viewed here.
- Business Wire
BlackRock Announces Increased Distribution Rates for Certain Closed-End Funds
NEW YORK, May 20, 2024--Today, the Board of Trustees of each of BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT), BlackRock Capital Allocation Term Trust (NYSE: BCAT), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Science and Technology Term Trust (NYSE: BSTZ), and BlackRock Innovation and Growth Term Trust (NYSE: BIGZ) (each a "Fund," and collectively the "Funds") announced increased distribution rates under each Fund’s managed distribution plan ("Plan"). Each Fund has ad
